Degradation kinetics of larotaxel and identification of its degradation products in alkaline condition

Bibliographic Details
Title: Degradation kinetics of larotaxel and identification of its degradation products in alkaline condition
Authors: Xiaoming Liang, Zhenzhen Liu, Huiyan Shi, Yuanyuan Zhang, Shixiao Wang, Kaishun Bi, Xiaohui Chen
Source: Journal of Pharmaceutical Analysis, Vol 7, Iss 2, Pp 118-122 (2017)
Publisher Information: Elsevier, 2017.
Publication Year: 2017
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: Larotaxel, Degradation kinetics, pH, Temperature, Degradation products, Therapeutics. Pharmacology, RM1-950
More Details: Larotaxel, a new taxane compound prepared by partial synthesis from 10-deacetyl baccatin III, is active against tumors. In this research, a selective LC-MS method was developed and validated for the study of degradation kinetics of larotaxel, which was carried out in aqueous solutions with different pH (1.5, 3.0, 5.0, 6.5, 7.4, 9.0, 10 and 11.0) and temperature (0, 25, 37 and 45 °C). The linear range was 0.5–25 μg/mL, the intra- and inter-day precisions were less than 7.0%, and accuracy ranged from 97.4–104.5% for each analyte. The observed rate obtained by measuring the remaining intact larotaxel was shown to follow first-order kinetics. The activation energies for degradation were 126.7 and 87.01 kJ/mol at pH 1.5 and 11, respectively. Although larotaxel was stable in pH 5, 6.5 and 7.4 buffers at 37 °C for 24 h during our study, increasing or decreasing the pH of the solutions would decrease its stabilities. Moreover, three main degradation products in alkaline condition were separated by HPLC and identified by Q-TOF-MS. The three degradation products were confirmed as 10-deacetyl larotaxel, 7, 8-cyclopropyl baccatin Ⅲ and 10-deacetyl-7, 8-cyclopropyl baccatin Ⅲ.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2095-1779
Relation: http://www.sciencedirect.com/science/article/pii/S2095177916301216; https://doaj.org/toc/2095-1779
DOI: 10.1016/j.jpha.2016.11.002
Access URL: https://doaj.org/article/52e4003044c64632b9b3e410517c5a4f
Accession Number: edsdoj.52e4003044c64632b9b3e410517c5a4f
Database: Directory of Open Access Journals
More Details
ISSN:20951779
DOI:10.1016/j.jpha.2016.11.002
Published in:Journal of Pharmaceutical Analysis
Language:English